← FDA DRUG APPROVALS

FDA NDA · NDA021317

BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAIN

Sponsor: BAYER

APPLICATION
NDA021317
TYPE
NDA
ORIGINAL APPROVAL
2001-10-18
LATEST ACTION
2001-10-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

BAYER EXTRA STRENGTH ASPIRIN FOR MIGRAINE PAINDiscontinued
ASPIRIN 500MG · TABLET · ORAL

Approval history

2001-10-18Type 7 - Drug Already Marketed without Approved NDA · Original · standard — Review ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →